|
[Related PubMed/MEDLINE] Total Number of Papers: 37
|
|
|
[Display Entries]
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of
|
|
|
|
Abbreviation |
: CRYO |
Long Form |
: cryoprecipitate |
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2020 |
Analysis of the hemostatic therapy in liver transplantation guided by rotational thromboelastometry or conventional laboratory tests. |
CLTs, FFP, OLT, PCC, ROTEM |
2 |
2020 |
Blood transfusion utilization in hospitalized COVID-19 patients. |
COVID-19, PLTs, RBCs |
3 |
2020 |
The effect of pathogen inactivation on cryoprecipitate: a functional and quantitative evaluation. |
APH, MP, PI, PI-cryo, WB |
4 |
2019 |
Efficacy of a new pathogen-reduced cryoprecipitate stored 5 days after thawing to correct dilutional coagulopathy in vitro. |
FC |
5 |
2019 |
Influence of canine donor plasma hemostatic protein concentration on quality of cryoprecipitate. |
FFP, FVIII, vWF |
6 |
2018 |
Utilization of frozen plasma, cryoprecipitate, and recombinant factor VIIa for children with hemostatic impairments: An audit of transfusion appropriateness. |
FP, INR, rVIIa |
7 |
2017 |
Comparison of albumin, colloid osmotic pressure, von Willebrand factor, and coagulation factors in canine cryopoor plasma, cryoprecipitate, and fresh frozen plasma. |
COP, CPP, FFP, vWF |
8 |
2017 |
Factors affecting the quality of cryoprecipitate. |
--- |
9 |
2017 |
Fibrinogen Early In Severe Trauma studY (FEISTY): study protocol for a randomised controlled trial. |
FC, FEISTY |
10 |
2016 |
A study on blood product usage and wastage at the public hospital, Guyana. |
FFP, GPHC |
11 |
2015 |
Early cryoprecipitate for major haemorrhage in trauma: a randomised controlled feasibility trial. |
Fg, STANDARD |
12 |
2014 |
Activated clotting time of thrombelastography (T-ACT) predicts early postinjury blood component transfusion beyond plasma. |
PLTs, rTEG, T-ACT |
13 |
2014 |
Transfusion practice varies widely in cardiac surgery: Results from anational registry. |
FFP, PLT, RBC |
14 |
2014 |
[Contribution of central hospital laboratory to critical bleeding]. |
--- |
15 |
2013 |
Preoperative predictors of blood component transfusion in living donor liver transplantation. |
APTT, B. urea, BSA, Hb, Hct, INR, LDLT, MELD, PLT, PRCs, s-creatinine, T. proteins, TLC |
16 |
2012 |
Initial experiences with point-of-care rapid thrombelastography for management of life-threatening postinjury coagulopathy. |
FFP, INR, MRTG, POC, Pre-TEG, RBCs, rTEG, TEG, TG |
17 |
2012 |
[Therapeutic effects of epidermal growth factor (EGF) combined with plasma cryoprecipitate (CRYO) on the corneal injury induced by paraquat]. |
EGF, PQ |
18 |
2011 |
[Efficacy of cryoprecipitate transfusion for coagulopathy after cardiopulmonary bypass in thoracic aortic surgery]. |
FFP |
19 |
2010 |
Cryoprecipitate prepared from plasma frozen within 24 hours after phlebotomy contains acceptable levels of fibrinogen and VIIIC. |
FFP, FP24, vWF |
20 |
2009 |
Fresh frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome. |
ARDS, FFP, MOF, PLTs |
21 |
2007 |
Early versus late recombinant factor VIIa in combat trauma patients requiring massive transfusion. |
rFVIIa |
22 |
2007 |
Intraoperative assessment and quantification of coronary artery graft patency performed on or off cardiopulmonary bypass. |
CABG, FFP, LOS, OM, OPCAB, PDA, PLTs, RBCs, RCA, SVG |
23 |
2004 |
A rapid platelet function assay used to regulate platelet transfusion prophylaxis following cardiopulmonary bypass surgery. |
CPB, FFP |
24 |
2004 |
Unappreciated risk factors for transplant patients: HLA antibodies in blood components. |
FFP, HLA, PLTs, PP, RBCs, TRALI |
25 |
2001 |
Inhibition of intra-abdominal adhesions: a comparison of hemaseel APR and cryoprecipitate fibrin glue. |
FDA, FG |
26 |
2001 |
Prevention of Bleeding Complications in Neonates With Liver Failure Undergoing Surgery Using Recombinant Factor VIIa. |
CVC, FFP, GI, PCC |
27 |
2000 |
Adhesive strength of autologous fibrin glue. |
--- |
28 |
1998 |
A quicker preparation method for autologous fibrin glue. |
--- |
29 |
1995 |
Preparation of fibrin glue: a study of chemical and physical methods. |
AS, FG, PEG |
30 |
1994 |
Utilization and sources of blood components in Taiwan. |
BDA, FP, PLT, PRBC, RBC, WB |
31 |
1993 |
Kinetic and mechanical parameters of pure and cryoprecipitate fibrin. |
Fib |
32 |
1992 |
A non-computer-dependent prospective review of blood and blood component utilization. |
FFP, PLTs |
33 |
1990 |
Decreasing blood donor exposure in neonates on extracorporeal membrane oxygenation. |
DE, ECMO, FFP, PRBC |
34 |
1988 |
Blood component use in orthotopic liver transplantation. |
FFP, OLT, RDP |
35 |
1986 |
Preparation of stable lyophilized cryoprecipitate in the original frozen plasma bags. |
--- |
36 |
1980 |
Hepatitis B virus, hepatitis A virus and persistently elevated aminotransferases in hemophiliacs. |
AHF |
37 |
1978 |
Development of large-scale fractionation methods. VI. An improved method for preparation of antihemophilic factor. |
AHF |
|